Polydeoxyribonucleotides: Clinical Trials

9 trials of Polydeoxyribonucleotides, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 recruiting, 1 terminated, 1 unknown. 6 Phase 4, 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Terminated 1, Unknown 1
Not applicable2Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Polydeoxyribonucleotides: new trials by email Literature Review of Polydeoxyribonucleotides trials Research Report on Polydeoxyribonucleotides

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study for Facial Scar Remodeling Using Fractional Carbon Dioxide Laser Combined With PDRN Versus Fractional CO₂ Laser
Polydeoxyribonucleotide, Fractional CO2 laser assisted PDT - Facial Scarring
Phase 2RecruitingMisr University for Science and Technology362026-03-012026-03-16
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
Periodontal Access Flap (AF) + Combined Formulation of Hyaluronic acid and Polydeoxyribonucleotides (PNHA), Periodontal Access Flap (AF) - Periodontal Diseases, Wound Heal
Not applicableRecruitingQueen Mary University of London242024-10-212026-07-02
Effects and Safety of Epidural PDRN vs. Placebo
Polydeoxyribonucleotides, Normal saline - Spinal Stenosis Lumbar
Phase 4UnknownSeoul National University Hospital452019-11-012020-05-26
Polydeoxyribonucleotide (PDRN) for Cuff Regeneration
Polydeoxyribonucleotides, Normal saline - Rotator Cuff Tear
Phase 4CompletedChuncheon Sacred Heart Hospital792019-05-092022-06-24
Effect of PDRN in Post-operative Scars
Polydeoxyribonucleotide (PDRN) - Scar
Phase 4CompletedSeoul National University Bundang Hospital222019-02-012021-12-08
Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases
Polydeoxyribonucleotides - Scleroderma Disease
Phase 4TerminatedMastelli S.r.l252016-11-082021-09-16
Bundang Rehabilitative Impact Study of the Elbow Epicondylitis
3ml-Rejuvinex, 3ml-15%-dextrose solution - Lateral Epicondylitis
Phase 4CompletedSeoul National University Bundang Hospital402015-06-012017-04-20
Polydeoxyribonucleotide for Elbow Lateral Epicondylitis
Extensor Muscle Strengthening Exercise, Extracorporeal Shockwave Therapy, Saline injection (Octreotide LAR placebo) - Lateral Epicondylitis, Extracorporeal Shockwave Therapy
Not applicableCompletedChuncheon Sacred Heart Hospital482014-11-202024-12-31
Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers
Polydeoxyribonucleotide, 0.9% NaCl - Diabetic Ulcer, Foot Ulcer Unhealed
Phase 4CompletedUniversity of Messina2152007-10-012012-09-11

Conditions studied

Tennis Elbow (2)  ·  Cicatrix (1)  ·  Diabetes Mellitus (1)  ·  Fatty Liver (1)  ·  Foot Ulcer (1)  ·  Periodontal Attachment Loss (1)  ·  Periodontal Diseases (1)  ·  Periodontal Pocket (1)  ·  Rotator Cuff Injuries (1)  ·  Scleroderma, Diffuse (1)

Sponsors

Chuncheon Sacred Heart Hospital (2)  ·  Seoul National University Bundang Hospital (2)  ·  Mastelli S.r.l (1)  ·  Misr University for Science and Technology (1)  ·  Queen Mary University of London (1)  ·  Seoul National University Hospital (1)  ·  University of Messina (1)

Countries

South Korea (5)  ·  Italy (2)  ·  Egypt (1)  ·  United Kingdom (1)

Top investigators

Elena Calciolari, DDS, MS, PhD (1)  ·  Giulia Cattarini (1)  ·  Hyun-Kyung Do (1)  ·  Jae-Young Lim (1)  ·  Jung Won Shin, M.D., Ph.D. (1)  ·  Jung-Taek Hwang, MD,PhD (1)  ·  Simona Muratori, Dr (1)

Results publications

PMID 29094396